Cargando…
Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
Infection and viral entry of SARS-CoV-2 crucially depends on the binding of its Spike protein to angiotensin converting enzyme 2 (ACE2) presented on host cells. Glycosylation of both proteins is critical for this interaction. Recombinant soluble human ACE2 can neutralize SARS-CoV-2 and is currently...
Autores principales: | Capraz, Tümay, Kienzl, Nikolaus F, Laurent, Elisabeth, Perthold, Jan W, Föderl-Höbenreich, Esther, Grünwald-Gruber, Clemens, Maresch, Daniel, Monteil, Vanessa, Niederhöfer, Janine, Wirnsberger, Gerald, Mirazimi, Ali, Zatloukal, Kurt, Mach, Lukas, Penninger, Josef M, Oostenbrink, Chris, Stadlmann, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730730/ https://www.ncbi.nlm.nih.gov/pubmed/34927585 http://dx.doi.org/10.7554/eLife.73641 |
Ejemplares similares
-
Generation of enzymatically competent SARS‐CoV‐2 decoy receptor ACE2‐Fc in glycoengineered Nicotiana benthamiana
por: Castilho, Alexandra, et al.
Publicado: (2021) -
Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues
por: Kallolimath, Somanath, et al.
Publicado: (2023) -
In planta deglycosylation improves the SARS-CoV-2 neutralization activity of recombinant ACE2-Fc
por: Izadi, Shiva, et al.
Publicado: (2023) -
Pre-analytical sample stabilization by different sampling devices for PCR-based COVID-19 diagnostics
por: Hardt, Melina, et al.
Publicado: (2022) -
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
por: Gawish, Riem, et al.
Publicado: (2022)